← Back to Search

COVID-19 Prevention Education for Diverse Criminal Legal Involved Communities

N/A

Recruiting

Led By John Schneider, MD

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will look at how to engage people with law enforcement ties in COVID-19 prevention education & network mobilization to increase testing & vaccination. 800 participants will be enrolled in two arms.

Who is the study for?

This trial is for adults over 18 who spend most of their time in the recruitment area, speak English, and have had interactions with law enforcement. It's not for those unable to consent or currently showing COVID-19 symptoms as per CDC guidelines.Check my eligibility

What is being tested?

The study tests two methods to promote COVID-19 prevention among people involved with the legal system: one group receives educational sessions on prevention, while the other participates in a network-driven motivational program.See study design

What are the potential side effects?

Since this trial focuses on education and motivation rather than medical treatments, traditional side effects are not applicable. However, participants may experience stress or discomfort discussing health-related topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COVID-19 Testing

COVID-19 Vaccination

Trial Design

2Treatment groups

Active Control

Group I: Education ArmActive Control1 Intervention

The Education condition will include COVID-19 prevention messaging and an interactive activity reinforcing the messages. Testimonial videos will be played including those that describe the testing experience and motivations for testing. This approach combines self-affirmation with misinformation correction to take advantage of the ability to promote adaptive COVID-19 prevention behaviors.

Group II: Motivational ArmActive Control1 Intervention

Study participants randomized to the Motivational Intervention will receive the intervention using a social network diffusion approach. This is a Type I network intervention that includes specific training on mobilization of network members. The Motivational intervention will be based upon a previous workshop divided into four learning and practice modules.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor

1,004 Previous Clinical Trials

818,977 Total Patients Enrolled

11 Trials studying COVID-19

34,308 Patients Enrolled for COVID-19

John Schneider, MDPrincipal InvestigatorUniversity of Chicago

2 Previous Clinical Trials

1,508 Total Patients Enrolled

1 Trials studying COVID-19

1,328 Patients Enrolled for COVID-19

Russell Brewer, DrPHPrincipal InvestigatorUniversity of Chicago

Media Library

Education Clinical Trial Eligibility Overview. Trial Name: NCT05500274 — N/A

COVID-19 Research Study Groups: Education Arm, Motivational Arm

COVID-19 Clinical Trial 2023: Education Highlights & Side Effects. Trial Name: NCT05500274 — N/A

Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT05500274 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room to join this research project?

"Affirmative. According to the information on clinicaltrials.gov, this medical trial is presently recruiting participants. This research study was initially made public on March 1st 2023 and has recently been updated on May 5th 2023. 800 individuals are required from a single site for recruitment purposes."

Answered by AI

What is the cap for enrollment in this research endeavor?

"Affirmative, the information available on clinicaltrials.gov indicates that this research is presently seeking participants for enrolment. The trial was initially announced in early March of 2023 and subsequently modified at the beginning of May. 800 patients are expected to take part across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities

2023. "Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05500274.

All > Covid 19